This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/uk/511076-oxford-astrazeneca-vaccine-approved-uk/
The article has changed 2 times. There is an RSS feed of changes available.
Previous version
1
Next version
Version 0 | Version 1 |
---|---|
Oxford-AstraZeneca Covid-19 vaccine approved for use in the UK | Oxford-AstraZeneca Covid-19 vaccine approved for use in the UK |
(32 minutes later) | |
The MHRA, the UK drug regulator, has given approval to the Oxford-AstraZeneca vaccine to be used for immunization on British soil. The formula is the second one given the green light in the country. | The MHRA, the UK drug regulator, has given approval to the Oxford-AstraZeneca vaccine to be used for immunization on British soil. The formula is the second one given the green light in the country. |
The Medicines and Healthcare products Regulatory Agency (MHRA) gave the go-ahead as part of a “rolling review,” a fast-track process for new drugs that can be used during a health crisis, the regulator said on Wednesday. | The Medicines and Healthcare products Regulatory Agency (MHRA) gave the go-ahead as part of a “rolling review,” a fast-track process for new drugs that can be used during a health crisis, the regulator said on Wednesday. |
“I’m really pleased to say that the UK is now one step closer to providing a safe and effective vaccine to help in the fight against Covid-19 – a virus that has affected each and every one of us in some way – and in helping to save lives,” MHRA Chief Executive Dr. June Raine said in a statement. | “I’m really pleased to say that the UK is now one step closer to providing a safe and effective vaccine to help in the fight against Covid-19 – a virus that has affected each and every one of us in some way – and in helping to save lives,” MHRA Chief Executive Dr. June Raine said in a statement. |
Health Secretary Matt Hancock praised the development, saying it ended 2020 in “a moment of hope” for the country. | Health Secretary Matt Hancock praised the development, saying it ended 2020 in “a moment of hope” for the country. |
The vaccine, which is named AZD1222, was developed at Oxford University in collaboration with British-Swedish pharmaceutical giant AstraZeneca. The UK has already launched a national immunization campaign this month, using the Pfizer/BioNTech vaccine, called Tozinameran, which was developed by a US-German team of researchers. | The vaccine, which is named AZD1222, was developed at Oxford University in collaboration with British-Swedish pharmaceutical giant AstraZeneca. The UK has already launched a national immunization campaign this month, using the Pfizer/BioNTech vaccine, called Tozinameran, which was developed by a US-German team of researchers. |
AstraZeneca is currently involved with the Gamaleya Institute, the Russian developer of the Sputnik V Covid-19 vaccine, to explore whether a combination of the two formulas triggers a stronger immune response. An agreement on the project was signed last week. | |
Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
Previous version
1
Next version